Table 1.
Anthropometric, metabolic, and hemodynamic characteristics of subjects with untreated stage 2 hypertension (n = 10).
| Variables | |||
|---|---|---|---|
| Age (years) | 43 | ± | 9 |
| Weight (kg) | 88.6 | ± | 17.1 |
| Height (cm) | 176.8 | ± | 0.03 |
| Body mass index (kg.m−2) | 28.1 | ± | 3.2 |
| Glucose (mg.dL−1) | 89.9 | ± | 7.6 |
| Urea (mg.dL−1) | 32.4 | ± | 6.1 |
| Creatinine (mg.dL−1) | 1.01 | ± | 0.13 |
| Cholesterol (mg.dL−1) | 198 | ± | 30 |
| HDL (mg.dL−1) | 48 | ± | 15 |
| LDL (mg.dL−1) | 123 | ± | 23 |
| VLDL (mg.dL−1) | 26 | ± | 12 |
| Triglycerides (mg.dL−1) | 131 | ± | 58 |
| Microalbuminuria (mg.dL−1) | 0.41 | ± | 0.18 |
| C-reactive protein (mg.dL−1) | 0.45 | ± | 0.88 |
| SBP (mmHg) | 144 | ± | 7 |
| MAP (mmHg) | 120 | ± | 5 |
| DBP (mmHg) | 96 | ± | 4 |
Data presented as mean ± standard deviation; Abbreviations: HDL, high-density lipoprotein; LDL, low density lipoprotein; VLDL, very low-density lipoprotein; SBP, systolic blood pressure; MAP, mean arterial pressure; DBP, diastolic blood pressure.